ClinicalTrials.gov
public full text
Public Domain
Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fasting Conditions
Objective: To compare the single dose bioavailability of Torrent's Pantoprazole Sodium Delayed - Release Tablets 1 × 40 mg and PROTONIX® (Pantoprazole Sodium) Delayed - Release Tablets 1 × 40 mg of Wyeth Pharmaceutical Inc. Dosing periods were separated by a washout period of at least 7 days. Study Design: randomized, open label, two treatment, two period, two sequence, single dose, crossover study in healthy human adult subjects
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions#810937
- Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study#918353
- Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets#966570
- Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions#868119
- Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions#1032545
Record · ID 863042
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive